[Biotransformation of 2-methyl-3-o-tolyl-4-(3H)-quinazolinone (methaqualone)]. 1970

F R Preuss, and H Hoffmann-Pinther, and H Achenbach, and H Friebolin

UI MeSH Term Description Entries
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

F R Preuss, and H Hoffmann-Pinther, and H Achenbach, and H Friebolin
September 1963, Chemical & pharmaceutical bulletin,
F R Preuss, and H Hoffmann-Pinther, and H Achenbach, and H Friebolin
January 1970, Chemical & pharmaceutical bulletin,
F R Preuss, and H Hoffmann-Pinther, and H Achenbach, and H Friebolin
January 1970, Chemical & pharmaceutical bulletin,
F R Preuss, and H Hoffmann-Pinther, and H Achenbach, and H Friebolin
March 1966, Arzneimittel-Forschung,
F R Preuss, and H Hoffmann-Pinther, and H Achenbach, and H Friebolin
January 1970, Chemical & pharmaceutical bulletin,
F R Preuss, and H Hoffmann-Pinther, and H Achenbach, and H Friebolin
June 1969, Journal of chromatography,
F R Preuss, and H Hoffmann-Pinther, and H Achenbach, and H Friebolin
January 1963, Chemical & pharmaceutical bulletin,
F R Preuss, and H Hoffmann-Pinther, and H Achenbach, and H Friebolin
May 1963, Archives internationales de pharmacodynamie et de therapie,
F R Preuss, and H Hoffmann-Pinther, and H Achenbach, and H Friebolin
January 1963, Medical times,
Copied contents to your clipboard!